BLIS Technologies Ltd
NZX:BLT

Watchlist Manager
BLIS Technologies Ltd Logo
BLIS Technologies Ltd
NZX:BLT
Watchlist
Price: 0.015 NZD -6.25% Market Closed
Market Cap: 19.2m NZD
Have any thoughts about
BLIS Technologies Ltd?
Write Note

BLIS Technologies Ltd
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

BLIS Technologies Ltd
Capital Expenditures Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
BLIS Technologies Ltd
NZX:BLT
Capital Expenditures
-NZ$569k
CAGR 3-Years
28%
CAGR 5-Years
-34%
CAGR 10-Years
N/A
A
AFT Pharmaceuticals Ltd
NZX:AFT
Capital Expenditures
-NZ$8.6m
CAGR 3-Years
-19%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
Cannasouth Ltd
NZX:CBD
Capital Expenditures
-NZ$345.2k
CAGR 3-Years
-59%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
Rua Bioscience Ltd
NZX:RUA
Capital Expenditures
-NZ$1.2k
CAGR 3-Years
90%
CAGR 5-Years
69%
CAGR 10-Years
N/A
G
Greenfern Industries Ltd
NZX:GFI
Capital Expenditures
-NZ$532.5k
CAGR 3-Years
25%
CAGR 5-Years
-231%
CAGR 10-Years
N/A
No Stocks Found

BLIS Technologies Ltd
Glance View

Market Cap
19.2m NZD
Industry
Pharmaceuticals

BLIS Technologies Ltd. engages in the development of healthcare products based on strains of bacteria that produce Bacteriocin activity. The company is headquartered in Dunedin, Otago. The company went IPO on 2001-07-30. The firm is also engaged in supply of healthcare ingredients and the manufacture of part and finished goods and food products for sale in domestic and international markets. The firm supplies BLIS-branded finished goods. The firm's products include BLIS K12 and BLIS M18, which are oral probiotics providing protection for ear, nose and throat health, halitosis (bad breath), gums and teeth health and immune support. The firm distributes its products through Stratum Nutrition in North America, NZPR Group in China, and Bluestone Pharma in Europe and Middle East. Its other BLIS branded products include Throat Guard EVERYDAY BLIS K12, Travel Guard BLIS K12, Fresh Breath Kit K12 and Toddler Protect BLIS K12 Powder for Toddlers.

BLT Intrinsic Value
0.01 NZD
Overvaluation 34%
Intrinsic Value
Price

See Also

What is BLIS Technologies Ltd's Capital Expenditures?
Capital Expenditures
-569k NZD

Based on the financial report for Mar 31, 2024, BLIS Technologies Ltd's Capital Expenditures amounts to -569k NZD.

What is BLIS Technologies Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-34%

Over the last year, the Capital Expenditures growth was -487%. The average annual Capital Expenditures growth rates for BLIS Technologies Ltd have been 28% over the past three years , -34% over the past five years .

Back to Top